Amgen
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Wikipedia
GILD (NasdaqGS) $68.40 -0.24 (-0.35%)
Tue, Jul 2, 2024, 4:00PM EDT